O'Connor Donal
SEC insider (Form 3/4/5 filer). CIK 0001625377. Director at Theravance Biopharma, Inc. (TBPH) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies O'Connor Donal has filed insider reports for
- Theravance Biopharma, Inc. (TBPH): Director
- PERRIGO Co plc (PRGO): Director
O'Connor Donal
CIK: 0001625377
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect74.2K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect6K shares- - Jun 12, 2026TBPH
Theravance Biopharma, Inc.
AwardDirect6K shares- - May 14, 2026PRGO
PERRIGO Co plc
Tax PaymentDirect3.5K shares at avg. $10.84$38K - May 14, 2026PRGO
PERRIGO Co plc
ExerciseDirect7.3K shares at avg. $10.84$79K - May 13, 2026PRGO
PERRIGO Co plc
AwardDirectRestricted Stock Units
16.7K shares- - May 19, 2025TBPH
Theravance Biopharma, Inc.
AwardDirect10.6K shares- - May 14, 2025PRGO
PERRIGO Co plc
Tax PaymentDirect4.8K shares at avg. $26.01$124K - May 14, 2025PRGO
PERRIGO Co plc
ExerciseDirect9.9K shares at avg. $26.01$258K - May 14, 2025PRGO
PERRIGO Co plc
AwardDirectRestricted Stock Units
7.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  TBPH Theravance Biopharma, Inc. | Disposition | 74,204 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 6,009 | - | $0 | Direct |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc. | Award | 6,009 | - | $0 | Direct |
| May 14, 2026 |  PRGO PERRIGO Co plc | Tax Payment | 3,507 | $10.84 | $38,016 | Direct |
| May 14, 2026 | PRGO PERRIGO Co plc | Exercise | 7,305 | $10.84 | $79,186 | Direct |
| May 13, 2026 | PRGO PERRIGO Co plc | Award Restricted Stock Units | 16,681 | - | - | Direct |
| May 19, 2025 | TBPH Theravance Biopharma, Inc. | Award | 10,649 | - | - | Direct |
| May 14, 2025 | PRGO PERRIGO Co plc | Tax Payment | 4,754 | $26.01 | $123,652 | Direct |
| May 14, 2025 | PRGO PERRIGO Co plc | Exercise | 9,904 | $26.01 | $257,603 | Direct |
| May 14, 2025 | PRGO PERRIGO Co plc | Award Restricted Stock Units | 7,305 | - | - | Direct |
1-10 of 10 transactions